CLINICAL_TRIALS
trial_result
· 2018-07-26
Clinical Trial Update: CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) [Phase 2]
Summary
Phase 2 clinical trial update for CyclASol in moderate to severe dry-eye disease completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novaliq GmbH | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2018-07-26